SLC6A1 NEURODEVELOPMENTAL DISORDER (NDD)

Clinical trials for SLC6A1 NEURODEVELOPMENTAL DISORDER (NDD) explained in plain language.

Never miss a new study

Get alerted when new SLC6A1 NEURODEVELOPMENTAL DISORDER (NDD) trials appear

Sign up with your email to follow new studies for SLC6A1 NEURODEVELOPMENTAL DISORDER (NDD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New study tracks rare childhood brain disorder to pave way for future treatments

Knowledge-focused Not yet recruiting

This study follows 60 children with SLC6A1-NDD, a rare genetic condition causing seizures and developmental delays. Researchers will track seizures, behavior, and development over time to better understand the disease. The goal is to prepare for future clinical trials by learning…

Matched conditions: SLC6A1 NEURODEVELOPMENTAL DISORDER (NDD)

Sponsor: UCB Biopharma SRL • Aim: Knowledge-focused

Last updated May 06, 2026 16:13 UTC

SLC6A1 NEURODEVELOPMENTAL DISORDER (NDD)

Get alerted when new SLC6A1 NEURODEVELOPMENTAL DISORDER (NDD) trials appear

New study tracks rare childhood brain disorder to pave way for future treatments